Gabon vs India: Average cost of drugs for extensively drug-resistant tuberculosis
Gabon
995 constant 2022 US$
in 2024
India
1,203 constant 2022 US$
in 2024
Gabon rank
42nd
India rank
39th
Average cost of drugs for extensively drug-resistant tuberculosis over time
- Gabon
- India
How they compare
India currently reports 1,203 constant 2022 US$ against 995 constant 2022 US$ in Gabon, a difference of 208 constant 2022 US$.
That makes India's figure about 1.2 times Gabon's.
The two have swapped places 2 times across 5 shared years of data; in 2020 it was India ahead.
Gabon ranks 42nd and India ranks 39th of 56 countries.
Gabon has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher average cost of drugs for extensively drug-resistant tuberculosis, Gabon or India?
- India, at 1,203 constant 2022 US$ against 995 constant 2022 US$ in Gabon as of 2024.
- What is the difference in average cost of drugs for extensively drug-resistant tuberculosis between Gabon and India?
- 208 constant 2022 US$, with India ahead.
- How many years of comparable data are there for Gabon and India?
- 5 years are reported by both, from 2020 to 2024.
- How do Gabon and India rank globally for average cost of drugs for extensively drug-resistant tuberculosis?
- Gabon ranks 42nd and India ranks 39th of 56 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.